Development and validation of RP HPLC method for determination of betamethasone dipropionate in gingival crevicular fluid

Bogdanovska, Liljana; Popovska, Mirjana; Dimitrovska, Aneta; Petkovska, Rumenka

doi:10.2478/acph-2013-0030

Abstract

A simple RP HPLC method for quantification of betamethasone dipropionate (BDP) in gingival crevicular fluid (GCF) has been developed and validated. GCF represents a valuable matrix for therapeutic monitoring of drugs used in the treatment of periodontal disease. The proposed method involves single step extraction for sample preparation. The calibration curve for BDP was linear over the concentration range of 0.10-2.00 μg mL^-1 (R² = 0.9971). RSD values of intra- and inter-day precision ranged 2.2-4.5 and 1.6-5.7 %, while accuracy values were higher than 96.6 and 97.0 %, respectively. The described method can be successfully applied for determination of betamethasone concentrations in GCF obtained from patients with chronic periodontitis after local treatment with BDP cream 0.5 mg g^-1.

References

1. W. V. Giannobile, T. Beikler, J. S. Kinney, C. A. Ramseier, T. Morelli and D. T. Wong, Saliva as a diagnostic tool for periodontal disease: current state and future directions, Periodontol. 2000 50 (2009) 52-64; DOI: 10.1111/j.1600-0757.2008.00288.x.10.1111/j.1600-0757.2008.00288.x
Search in Google Scholar
2. J. S. Kinney, C. A. Ramseier and W. V. Giannobile, Oral fluid-based biomarkers of alveolar bone loss in periodontitis, Ann. N. Y. Acad. Sci. 1098 (2007) 230-251; DOI: 10.1196/annals.1384.028.10.1196/annals.1384.028
Search in Google Scholar
3. T. E. Van Dyke, Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases, J. Dent. Res. 8 (2003) 12-37; DOI: 10.1177/154405910308200202.10.1177/154405910308200202
Search in Google Scholar
4. R. A. Seymour, Effects of medications on the periodontal tissues in health and disease, Periodontol.2000 40 (2006) 120-129; DOI: 10.1111/j.1600-0757.2005.00137.x.10.1111/j.1600-0757.2005.00137.x
Search in Google Scholar
5. H. Aras, F. Çaglayan, G. N. Güncü, A. Berberoìlu and K. Kilinc, Effect of systematically administered naproxen sodium on clinical parametars and myeloperoxidase and elastase - like activity levels in gingival crevicular fluid, J. Periodontol. 78 (2007) 868-873; DOI: 10.1902/jop.2007. 060412.
Search in Google Scholar
6. E. Fachin and A. Zaki, Histology and lysosomal cytochemistry of the postsurgically inflamed dental pulp after topical application of steroids. Histological study, J. Endod. 9 (1991) 457-460; DOI: 10.1016/S0099-2399(07)80137-3.10.1016/S0099-2399(07)80137-3
Search in Google Scholar
7. E. Fachin, R. Scarparo, A. Pezzi, S. Luisi and M. Filho, Effect of betamethasone on the pulp after topical application to the dentin of rat teeth: vascular aspects of inflammation, J. Appl. Oral Sci. 17 (2009) 335-339; DOI: 10.1590/S1678-77572009000400012.10.1590/S1678-77572009000400012
Search in Google Scholar
8. L. K. Pershing, L. D. Lambert, V. P. Shah and S. Y. Lam, Variability and correlation of chromametar and tape-stripping methods with the visual skin blaching assay in the quantitative assessment of topical 0.05 % betamethasone dipropionate bioavailability in humans, Int. J. Pharm. 86 (1992) 201-210; DOI: 10.1016/0378-5173(92)90198-B.10.1016/0378-5173(92)90198-B
Search in Google Scholar
9. J. Zou, L. Ding, D. Xiao, Z. Bin, H. Fan, L. Liu and J. Wang, Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography - positive- -negative electrospray ionisation tandem mass spectrometry, J. Chromatogr. B 873 (2008)159 -164, DOI: 10.1016/j.jchromb.2008.08.011.10.1016/j.jchromb.2008.08.011
Search in Google Scholar
10. M. Koss, S. Castro and M. Lopez, Enzymatic profile of gingival crevicular fluid in association with periodontal status, Lab. Med. 40 (2009) 277-280; DOI: 10.1309/LMCNUQI8ULCUK2BK.10.1309/LMCNUQI8ULCUK2BK
Search in Google Scholar
11. I. B. Lamster and J. K. Aclo, Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases, Ann. N. Y. Acad. Sci. 1098 (2007) 216-229; DOI: 10.1196/annals.1384. 027.
Search in Google Scholar
12. D. S. Vienneau and C. G. Kindberg, Development and validation of a sensitive method for tetracycline in gingival crevicular fluid by HPLC using fluorescence detection, J. Pharm. Biomed. Anal. 16 (1997) 111-117; DOI: 10.1016/S0731-7085(97)00009-5.10.1016/S0731-7085(97)00009-5
Search in Google Scholar
13. C. E. Castro, M. A. Koss and M. E. Lopez, Intracytoplasmic enzymes in gingival crevicular fluid of patients with aggressive periodontitis, J. Periodont. Res. 46 (2011) 522-527; DOI: 10.1111/j. 1600-0765.2011.01367.x.
Search in Google Scholar
14. EMEA, Committee for Medicinal Products for Human Use, Draft Guidelines on Validation of BioanalyticalMethods, EMEA, London 2009.
Search in Google Scholar
15. C. C. Tsai, C. C. Kao and C. C. Chen, Gingival crevicular fluid lactoferrin levels in adult periodontitis, Aust. Dent. J. 43 (1998) 40-44; DOI: 10.1111/j.1834-7819.1998.tb00151.x. 10.1111/j.1834-7819.1998.tb00151.x9583225
Search in Google Scholar

Development and validation of RP HPLC method for determination of betamethasone dipropionate in gingival crevicular fluid

Abstract

Paradigm

My account